Stock Alerts

It’s not just Treasuries–how about the rout from AI debt at Oracle?

It’s not just Treasuries–how about the rout from AI debt at Oracle?

On Thursday Oracle’s (ORCL) credit default swaps spiked to record highs. Investors are worried at the size of Oracle’s debt load. And wonder if profits will arrive early enough to meet the debt burden. Oracle isn’t an isolated worry–it’s just the poster child for debt pressure facing AI companies. A big question, one of several, giving investors a reason not to buy stocks in the AI sector despite more reasonable valuations is whether profits from AI revenue growth will materialize before these companies have to pay the rising costs of borrowing to build out AI infrastructure.On Thursday, the cost OF Oracle’s debt reached unprecedented levels. At the same time the company’s borrowing costs surged, with the yield on its 6.7% bonds maturing in 2056 crossing 8% for the first time, according to Zerohedge.

Time to build a metals ladder–and to put short-term volatility and the long-term trend on your side

Time to build a metals ladder–and to put short-term volatility and the long-term trend on your side

A metals ladder? What’s that?You’re probably familar with the concept of a bond ladder. A bond ladder is a portfolio of individual bonds with maturity dates spread out at regular intervals. Instead of investing all your fixed-income money in one bond that matures on one date, you divide your investment among several bond “rungs,” so some principal comes due periodically. If you reinvest each maturing rung at the longest maturity, the ladder becomes self-renewing: one investment matures every year, and you invest the proceeds from each maturing bond into a new five-year (or longer) bond. A ladder is a way to manage the trade-off among yield, liquidity, and uncertainty about future interest rates. A metals ladder, in the current market, has a simlar goal–to manage and profit from the long-term trends of high inflation, a falling dollar, and uncertainty in the monetary system. It seeks to turn the current uncertainties about the pace of economic growth, the rate of inflation, the pace of interest rate increases, and the speed of the developing debt crisis into the rules and timing for buying and selling gold, silver, and copper.
Crucial to any metals ladder is the different economic charateristics of gold, silver, and copper.

Walmart earnings disappointment, consumer confidence drops–time to walk toward exits on more consumer stocks PEP, BUD

Walmart earnings disappointment, consumer confidence drops–time to walk toward exits on more consumer stocks PEP, BUD

I’m not runnimg to the exits for consumer stocks but I am taking a brisk walk. Tomorrow, Wednesday, August 26, I will sell Anheuser-Busch InBev (BUD) out of my Jubak Picks Portfolio with a gain of 35.82% as of the close on August 25 since I established the position on January 30, 2022. The shares are down 4.97% in the last three months but up 25.69% for 2026.
Tomorrow, Wednesday, August 26, I will sell PepsiCo (PEP) out of my Jubak Picks Porfolio with a loss of 17.91% since I established the position on April 27, 2022. I will keep a long-term position in PepsiCo in my 50 Stocks Portfolio. The stock is down 2.94% in the last three months but up 2.82% for 2026.

Saturday Night Quarterback says, For the week ahead expect…

Saturday Night Quarterback says, For the week ahead expect…

At the miment, For the reasons I’ve stated in this post I think risks are weightd to the downside on earnings. So on Monday, August 24, I’m going to sell my position in Nvidia in my long-term 50 Stocks Portfolio. That position is up 5.2% since I started it on July 8. I will re-evaluate this position after earnings with a strong likelihood of rebuying on any sell off.

Saturday Night Quarterback says, For the week ahead expect…

Time to rebuy Nvidia in my long-term 50 Stocks Portfolio

I sold Nvidia (NVDA) out go my long-term 50 Stocks Portfolio on March 18 at a closing price of $180.40 My thinking then was that after a huge run Nvidia’s share had moved to an excessively optomistic valuation and it was time to give the shares a rest with expectations that the shares would correct and offer a lower rick re-entry price.
Turns out I was a “bit” early. Nvidia continued to climb until it hit an all-time high of $235.47. The shares closed at $196.93 on July 7. Now, though, I see the rebuying opportunity I was expecting. After losing roughly $1 trillion in market value in less than two months, Nvidia Corp.’s stock is the cheapest it’s been since before the AI boom kicked off and sent the shares into the stratosphere.

Add to positions in AbbVie on latest acquisition

Add to positions in AbbVie on latest acquisition

I’ve owned shares of AbbVie (ABBV) in my Diividend Portfolio since January 29, 22020. The gain during that period through the close on June 30 has been 201% plus dvidends. (The stock currently pays a 2.72% forward dividend.)
Besides my adding to me position in the Dividend Portfolio, I will adding a new position in my Jubak Picks Portfolio tomorrow, July 1.
The challenge during most of that time has been how the drug maker would find the revenue growth to make up for the gradual erosion of revenue from its blockbuster Humira as that drug came off patent. AbbVie has done a good job in that transition and the deal to buy Apogee Therapeutics for $10.9 billion will bolster its portfolio of anti-inflammatory drugs amid growing competition for its best-selling Skytizi.

So exactly how bad are things down on the farm?

So exactly how bad are things down on the farm?

Last year, America’s crop farmers lost $34.6 billion, and farm bankruptcies surged to numbers not seen since 2020, according to the American Farm Bureau Federation. This year, 70% of farmers surveyed claim they cannot afford all the fertilizers they need. Fuel costs continue to rise as the Strait of Hormuz remains closed. Prices for some fertilizers are up 47% year over year. Meanwhile, farm exports to China, Canada, and other countries have taken a huge hit from U.S. tariff policy. Ninety-four percent of farmers reported that their financial situation has “worsened or remained the same” since last year. Fifteen thousand farms closed in 2025.
Bankruptcies were up 55% in 2024, 46% in 2025 and 70% for 2026 by May.

Lilly adds a new weight-loss drug and revenue growth above expectations

Lilly adds a new weight-loss drug and revenue growth above expectations

What do the stocks of AI chip maker Nvidia (NVDA) and weight-loss drug leader Eli Lilly (LLY) have in common? Their lofty valuations depend on years and years of fast growth.
At a trailing 12-month price to earnings ratio, Nvidia isn’t especially expensive–as ling as it can grow revenue at the 81% rate projected for 2027 or even the 39% projected for 2028. The worry–what makes investors nervous about Nvidia is evidence of increasing competition in the are for AI chips. At some point, the worries go, chips from Amazon, Alphabet, Meta Platforms, and Chinese competitors have to start taking market share. How much and when? boom the important issues.
Same with shares of Eli Lily. At a trailing 12-month price to earning ratio of 37 an a forward PE of 28 on the next 12-month’s earnings per share, Eli Lilly isn’t expense as ling as it can keep growing revenue at the 31% projected for 2026. But revenue growth is projected at just 15% for 2027 on analysts belief that patent expirations and competition in the market for GLP-1 weight loss drugs will slow growth.
It’s important for investors in Eli Lilly that growth for 2027 and beyond comes in higher than that.
And the company’s recent earning report band its announcement of the preliminary trial results for a new weight loss drug offer reason for optimism.